3 completed, 3 recruiting, 1 active not recruiting, 1 enrolling by invitation. 11 Phase 2, 4 Phase 1, 1 Phase 3.
Follow Schizo Affective Disorder: new trials by email Literature Review of Schizo Affective Disorder trials Research Report on Schizo Affective Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy Sigma-Stim, RUL LAP-ST (Low-Amplitude Pulse Seizure Therapy - Right Unilateral) - Suicidal Ideation, Major Depressive Disorder | Phase 2 / Phase 3 | Active not recruiting | Michigan State University | 30 | 2024-07-03 | 2026-11-02 |
| D-serine AudRem: R33 Phase D-serine, Placebo - Schizophrenia, Schizo Affective Disorder | Phase 1 / Phase 2 | Suspended | New York State Psychiatric Institute | 60 | 2022-12-01 | 2026-11-02 |
| Rituximab Treatment for Psychosis And/or Obsessive Compulsive Disorder with Probable Immune System Involvement Rituximab - Obsessive-Compulsive Disorder, Obsessive-Compulsive Behavior | Phase 2 | Enrolling by invitation | Uppsala University Hospital | 40 | 2022-05-01 | 2024-11-19 |
| Acetazolamide for Treatment Resistant Schizophrenia Acetazolamide, Placebo - Schizophrenia, Schizo Affective Disorder | Phase 1 / Phase 2 | Recruiting | Vishwajit Nimgaonkar, MD PhD | 60 | 2022-02-01 | 2026-07-07 |
| Neurotransmitters in Treatment Resistant Schizophrenia Patients With add-on Sodium Benzoate Sodium Benzoate 2gram/day, Placebo - Symptom, Cognitive, Schizophrenia | Phase 2 | Recruiting | National Cheng-Kung University Hospital | 90 | 2021-11-18 | 2026-06-16 |
| Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders Intranasal Insulin - Psychosis, Schizophrenia | Phase 2 | Completed | Mclean Hospital | 87 | 2019-10-01 | 2026-09-03 |
| L-arginine Study for Persistent Symptoms of Schizophrenia L-arginine, Sapropterin Dihydrochloride - Schizo Affective Disorder, Schizophrenia | Phase 2 | Withdrawn | University of Massachusetts, Worcester | 2019-09-11 | 2022-01-20 | |
| Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia Cromoglycate, Placebo - Schizophrenia, Schizo Affective Disorder | Phase 1 / Phase 2 | Recruiting | Vishwajit Nimgaonkar, MD PhD | 160 | 2019-04-01 | 2026-03-19 |
| D-serine Augmentation of Neuroplasticity D-serine, Placebo - Schizophrenia, Schizo Affective Disorder | Phase 1 / Phase 2 | Completed | New York State Psychiatric Institute | 45 | 2019-03-13 | 2022-06-14 |
| Telmisartan Pilot Study on Treatment Resistant Schizophrenia Telmisartan Pill - Schizophrenia, Schizo Affective Disorder | Phase 2 | Terminated | Xiaoduo Fan | 6 | 2019-02-01 | 2022-03-02 |
| Levetiracetam in Early Psychosis Levetiracetam, Placebo - Psychosis, Schizophrenia | Phase 2 | Completed | NYU Langone Health | 48 | 2017-08-18 | 2022-11-21 |
Psychotic Disorders (11) · Schizophrenia (10) · Schizophrenia, Treatment-Resistant (2) · Bipolar Disorder (1) · Compulsive Behavior (1) · Depression (1) · Depressive Disorder, Major (1) · Insulin Resistance (1) · Mental Disorders (1) · Neurobehavioral Manifestations (1) · Obsessive-Compulsive Disorder (1) · Schizophrenia, Paranoid (1) · Suicidal Ideation (1) · Suicide (1)
Schizophrenia Spectrum and Other Psychotic Disorders (11) · Mental Disorders (10) · Behavior (2) · Anxiety Disorders (1) · Behavioral Symptoms (1) · Bipolar and Related Disorders (1) · Depressive Disorder (1) · Glucose Metabolism Disorders (1) · Hyperinsulinism (1) · Impulsive Behavior (1) · Metabolic Diseases (1) · Mood Disorders (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Nutritional and Metabolic Diseases (1)
Acetazolamide (1) · Arginine (1) · Cromolyn Sodium (1) · Insulin (1) · Levetiracetam (1) · Rituximab (1) · Telmisartan (1) · sapropterin (1)
New York State Psychiatric Institute (2) · Vishwajit Nimgaonkar, MD PhD (2) · Mclean Hospital (1) · Michigan State University (1) · NYU Langone Health (1) · National Cheng-Kung University Hospital (1) · University of Massachusetts, Worcester (1) · Uppsala University Hospital (1) · Xiaoduo Fan (1)
United States (9) · India (1) · Sweden (1) · Taiwan (1)
Donald Goff, MD (1) · Janet L Cunningham, MD PhD (1) · Nagy A Youssef, MD, PhD (1) · Virginie-Anne Chouinard, M.D. (1) · Vishwajit L Nimgaonkar, M.D., Ph.D. (1) · Vishwajit L. Nimgaonkar, M.D., Ph.D. (1) · Xiaoduo Fan (1) · Xiaoduo Fan, MD, MPH (1) · Yen-Kuang Yang, Dr (1)
PMID 36958998, PMID 37293030, PMID 37690312
2019 (1), R33MH116093 (1)